BPC
BIIB icon

Banque Pictet & Cie’s Biogen BIIB Stock Holding History

Banque Pictet & Cie’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,900
Closed -$440K – 303
2024
Q2 		$440K Hold
1,900
– – ﹤0.01% 268
2024
Q1 		$410K Sell
1,900
-950
-33% -$222K ﹤0.01% 288
2023
Q4 		$737K Buy
+2,850
New +$700K 0.01% 256

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Banque Pictet & Cie's BIIB Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Biogen (BIIB) stake by 1.5% in Q2 2026, selling an estimated $188K and leaving 65,080 shares worth $14.1M. The position accounts for 0.09% of the portfolio, ranked #85.

Banque Pictet & Cie first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $18.5M in Q4 2021. 430 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Banque Pictet & Cie held 65,080 shares of Biogen worth $14.1M as of Q2 2026.
  • Banque Pictet & Cie sold 981 Biogen shares in Q2 2026, an estimated $188K.
  • Biogen made up 0.09% of Banque Pictet & Cie's portfolio in Q2 2026, its #85 holding.
  • Banque Pictet & Cie first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
  • Banque Pictet & Cie's Biogen position peaked at $18.5M in Q4 2021.
  • 430 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.